[1]陈 曦,寇 天.小牛血清去蛋白联合奥扎格雷钠治疗急性脑梗死的疗效[J].医学信息,2019,32(16):143-145.[doi:10.3969/j.issn.1006-1959.2019.16.048]
　CHEN Xi,KOU Tian.Efficacy of Calf Serum Deproteination Combined with Sodium Ozagrel in the Treatment of Acute Cerebral Infarction[J].Journal of Medical Information,2019,32(16):143-145.[doi:10.3969/j.issn.1006-1959.2019.16.048]
点击复制

小牛血清去蛋白联合奥扎格雷钠治疗急性脑梗死的疗效()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年16期
页码:
143-145
栏目:
药物与临床
出版日期:
2019-08-15

文章信息/Info

Title:
Efficacy of Calf Serum Deproteination Combined with Sodium Ozagrel in the Treatment of Acute Cerebral Infarction
文章编号:
1006-1959（2019）16-0143-03
作者:
陈 曦1; 寇 天2
1.佳木斯市中心医院神经内一科, 黑龙江 佳木斯 154002； 2.佳木斯市中医院检验科，黑龙江 佳木斯 154002
Author(s):
CHEN Xi1; KOU Tian2
1.Department of Neurology,Subject One,Jiamusi Central Hospital,Jiamusi 154002,Heilongjiang,China; 2.Department of Clinical Laboratory,Jiamusi City Hospital of Traditional Chinese Medicine, Jiamusi 154002,Heilongjiang,China
关键词:
急性脑梗死; 小牛血清去蛋白; 奥扎格雷钠; 神经功能
Keywords:
Key words：Acute cerebral infarction; Calf serum deproteination; Sodium ozagrel; Neurological function
分类号:
R743.3
DOI:
10.3969/j.issn.1006-1959.2019.16.048
文献标志码:
A
摘要:
目的 探讨小牛血清去蛋白联合奥扎格雷钠对急性脑梗死患者神经功能的影响。方法 选取我院2018年1月~2019年1月收治的114例急性脑梗塞患者为研究对象。按照随机数表法分为对照组和研究组，每组57例。对照组采用奥扎格雷钠治疗，研究组在对照组基础上加用小牛血清去蛋白注射液治疗，疗程2周。比较两组治疗前后神经功能缺损程度、生活能力评分，治疗后临床疗效及不良反应。结果 治疗后两组神经功能缺损程度及生活能力评分均较治疗前改善，且研究组优于对照组，差异有统计学意义（P＜0.05）；研究组总有效率为96.49%，高于对照组的84.21%，差异有统计学意义（P＜0.05）；研究组不良反应发生率为7.02%，高于对照组的3.51%，但差异无统计学意义（P＞0.05）。结论 小牛血清去蛋白联合奥扎格雷钠治疗急性脑梗死疗效确切，可显著改善患者的神经功能，提高生活能力，未明显增加不良反应。
Abstract:
Abstract：Objective To investigate the effects of calf serum deproteination combined with ozagrel sodium on neurological function in patients with acute cerebral infarction.Methods A total of 114 patients with acute cerebral infarction admitted to our hospital from January 2018 to January 2019 were enrolled. According to the random number table method, they were divided into control group and study group, with 57 cases in each group. The control group was treated with sodium ozagrel. The study group was treated with calf serum deproteinized injection on the basis of the control group for 2 weeks. The neurological deficits, life ability scores, clinical efficacy and adverse reactions after treatment were compared between the two groups. Results After treatment, the scores of neurological deficits and viability of the two groups were improved compared with those before treatment, and the study group was superior to the control group,the difference was statistically significant (P<0.05). The total effective rate of the study group was 96.49%, which was higher than that of the control group 84.21%,the difference was statistically significant (P<0.05). The incidence of adverse reactions in the study group was 7.02%, which was higher than that of the control group 3.51%, but the difference was not statistically significant (P>0.05). Conclusion Calf serum deproteination combined with sodium ozagrel is effective in the treatment of acute cerebral infarction, which can significantly improve the neurological function of patients and improve their living ability, without significantly increasing adverse reactions.

参考文献/References:

[1]黄惠英,谢孟桥,唐凌雯,等.急性脑梗死患者颈动脉粥样硬化斑块与Hcy、hs-CRP的相关关系[J].实用医药杂志,2018,23(4):295-299. [2]唐运立,韦武,李青,等.急性脑梗死药物治疗现状[J].临床合理用药杂志,2018,11(13):179-181. [3]马龙,凡奇,杨淼,等.急性脑梗死患者血清Hcy、UA和CRP水平变化及与颈动脉粥样硬化的关系[J].河北医药,2018,40(8):1180-1183. [4]王敏,李玉华,王宝英,等.小牛血去蛋白提取物注射液治疗缺血性脑卒中的临床疗效及其对同型半胱氨酸、C反应蛋白、D-二聚体水平的影响[J].实用心脑肺血管病杂志,2019,27(2):100-103. [5]鲍磊,马进,严明科,等.小牛血清去蛋白注射液联合奥扎格雷钠治疗老年急性脑梗死的临床研究[J].现代药物与临床,2017,32(2):196-200. [6]王刚.小牛血清去蛋白对急性脑梗死病人氧化应激及其血清IL-8、Fibulin-5和TNF-α水平的影响[J].中西医结合心脑血管病杂志,2017,15(4):481-483. [7]陈康,施晓军,金叶,等.天舒胶囊联合奥扎格雷钠治疗脑梗死的临床研究[J].现代药物与临床,2018,33(9):2202-2206.

相似文献/References:

[1]冯 湧.新一代抗凝血药阿加曲班的临床应用进展[J].医学信息,2018,31(02):43.[doi:10.3969/j.issn.1006-1959.2018.02.015]
　FENG Yong.Progress in Clinical Application of the New Generation Anticoagulant Agatripine[J].Journal of Medical Information,2018,31(16):43.[doi:10.3969/j.issn.1006-1959.2018.02.015]
[2]王 伟,宫秀群,余 亮.阿替普酶治疗急性脑梗死患者临床转归的影响因素[J].医学信息,2022,35(11):84.[doi:10.3969/j.issn.1006-1959.2022.11.022]
　WANG Wei,GONG Xiu-qun,YU Liang.The Influencing Factors of Clinical Outcome in Patients with Acute Cerebral Infarction Treated with Alteplase[J].Journal of Medical Information,2022,35(16):84.[doi:10.3969/j.issn.1006-1959.2022.11.022]
[3]陈建新.阿加曲班注射液治疗急性脑梗死的疗效及对血清VEGF、GLUT-1水平的影响[J].医学信息,2018,31(19):5.[doi:10.3969/j.issn.1006-1959.2018.19.002]
　CHEN Jian-xin.Effect of Argatroban Injection on Acute Cerebral Infarction and Its Effect on Serum VEGF and GLUT-1 Levels[J].Journal of Medical Information,2018,31(16):5.[doi:10.3969/j.issn.1006-1959.2018.19.002]
[4]刘 然.头颅MRI-DWI病灶数量及部位对脑梗死复发预测意义[J].医学信息,2018,31(22):172.[doi:10.3969/j.issn.1006-1959.2018.22.052]
　LIU Ran.The Significance of the Number and Location of MRI-DWI Lesions in Predicting the Recurrence of Cerebral Infarction[J].Journal of Medical Information,2018,31(16):172.[doi:10.3969/j.issn.1006-1959.2018.22.052]
[5]褚春沐.阿加曲班联合阿替普酶静脉溶栓治疗急性脑梗死的效果及对脑血管储备功能的影响[J].医学信息,2022,35(13):133.[doi:10.3969/j.issn.1006-1959.2022.13.031]
　CHU Chun-mu.Effect of Argatroban Combined with Alteplase Intravenous Thrombolysis on Acute Cerebral Infarction and its Effect on Cerebrovascular Reserve Function[J].Journal of Medical Information,2022,35(16):133.[doi:10.3969/j.issn.1006-1959.2022.13.031]
[6]徐润鸿.血府逐瘀汤联合阿托伐他汀钙治疗急性脑梗死的临床观察[J].医学信息,2019,32(05):165.[doi:10.3969/j.issn.1006-1959.2019.05.054]
　XU Run-hong.Clinical Observation on Treatment of Acute Cerebral Infarction with Xuefu Zhuyu Decoction Combined with Atorvastatin Calcium[J].Journal of Medical Information,2019,32(16):165.[doi:10.3969/j.issn.1006-1959.2019.05.054]
[7]王丹丹,王学建.动脉自旋标记在急性脑梗死中的应用[J].医学信息,2019,32(12):102.[doi:10.3969/j.issn.1006-1959.2019.12.031]
　WANG Dan-dan,WANG Xue-jian.Application of Arterial Spin Labeling in Acute Cerebral Infarction[J].Journal of Medical Information,2019,32(16):102.[doi:10.3969/j.issn.1006-1959.2019.12.031]
[8]赵宏伟.急性脑梗死的危险因素及临床诊治研究[J].医学信息,2019,32(18):44.[doi:10.3969/j.issn.1006-1959.2019.17.015]
　ZHAO Hong-wei.Risk Factors and Clinical Diagnosis and Treatment of Acute Cerebral Infarction[J].Journal of Medical Information,2019,32(16):44.[doi:10.3969/j.issn.1006-1959.2019.17.015]
[9]陶 林,马 婷.丁苯酞注射液、胶囊序贯疗法辅治急性进展性脑梗死的 疗效及其对神经功能的影响[J].医学信息,2019,32(18):135.[doi:10.3969/j.issn.1006-1959.2019.18.045]
　TAO Lin,MA Ting.Efficacy of Butylphthalide Injection and Capsule Sequential Therapy in the Treatment of Acute Progressive Cerebral Infarction and Its Effect on Neurological Function[J].Journal of Medical Information,2019,32(16):135.[doi:10.3969/j.issn.1006-1959.2019.18.045]
[10]朱丽娜,王宗立,顾萌萌.UA、Hcy和FIB与颈动脉粥样硬化斑块及 脑梗死关系的分析[J].医学信息,2019,32(18):173.[doi:10.3969/j.issn.1006-1959.2019.18.061]
　ZHU Li-na,WANG Zong-li,GU Meng-meng.Analysis of the Relationship Among UA, Hcy，FIB and Carotid Atherosclerotic Plaque， Cerebral Infarction[J].Journal of Medical Information,2019,32(16):173.[doi:10.3969/j.issn.1006-1959.2019.18.061]

更新日期/Last Update: 2019-08-15